BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7428335)

  • 1. Choline bitartrate treatment of Alzheimer-type dementias.
    Fovall P; Dysken MW; Lazarus LW; Davis JM; Kahn RL; Jope R; Finkel S; Rattan P
    Commun Psychopharmacol; 1980; 4(2):141-5. PubMed ID: 7428335
    [No Abstract]   [Full Text] [Related]  

  • 2. Choline in Alzheimer's disease.
    Renvoize EB; Jerram T
    N Engl J Med; 1979 Aug; 301(6):330. PubMed ID: 377082
    [No Abstract]   [Full Text] [Related]  

  • 3. A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease).
    Brinkman SD; Pomara N; Goodnick PJ; Barnett N; Domino EF
    J Clin Psychopharmacol; 1982 Aug; 2(4):281-5. PubMed ID: 7119136
    [No Abstract]   [Full Text] [Related]  

  • 4. Cognitive and behavioral sensitivity to scopolamine in Alzheimer patients and controls.
    Sunderland T; Tariot PN; Mueller EA; Murphy DL; Weingartner H; Cohen RM
    Psychopharmacol Bull; 1985; 21(3):676-9. PubMed ID: 3898182
    [No Abstract]   [Full Text] [Related]  

  • 5. Choline chloride in Alzheimer disease.
    Thal LJ; Rosen W; Sharpless NS; Crystal H
    Ann Neurol; 1981 Dec; 10(6):580. PubMed ID: 7325608
    [No Abstract]   [Full Text] [Related]  

  • 6. Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementias.
    Grossman F; Okamoto A; Turkoz I; Gharabawi G
    J Am Geriatr Soc; 2004 May; 52(5):852-3. PubMed ID: 15086685
    [No Abstract]   [Full Text] [Related]  

  • 7. Choline therapy in Alzheimer's disease.
    Smith CM; Swash M; Exton-Smith AN; Phillips MJ; Overstall PW; Piper ME; Bailey MR
    Lancet; 1978 Aug; 2(8084):318. PubMed ID: 79110
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurochemical approaches to the treatment of senile dementia.
    Growdon JH; Corkin S
    Proc Annu Meet Am Psychopathol Assoc; 1980; 69():281-96. PubMed ID: 7413654
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results].
    Acierno G
    Clin Ter; 1983 Apr; 105(2):135-45. PubMed ID: 6345054
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease.
    Xu SS; Gao ZX; Weng Z; Du ZM; Xu WA; Yang JS; Zhang ML; Tong ZH; Fang YS; Chai XS
    Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):391-5. PubMed ID: 8701750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing treatment guidelines for Alzheimer's disease and other dementias.
    Rabins PV
    J Clin Psychiatry; 1996; 57 Suppl 14():37-8. PubMed ID: 9024335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choline chloride fails to improve cognition of Alzheimer's disease.
    Thal LJ; Rosen W; Sharpless NS; Crystal H
    Neurobiol Aging; 1981; 2(3):205-8. PubMed ID: 7312098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
    Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Citalopram in treatment of behavioral disorders in demented patients].
    Leblhuber F
    Acta Med Austriaca; 1994; 21(4):104-6. PubMed ID: 7871964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dementia syndromes and epilepsy].
    Paggi A; Quattrini A; Ortenzi A; Cianci F; Silvestri R; Mancini S
    Minerva Med; 1984 Feb; 75(6):249-51. PubMed ID: 6709209
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical effects of choline in Alzheimer senile dementia.
    Boyd WD; Graham-White J; Blackwood G; Glen I; McQueen J
    Lancet; 1977 Oct; 2(8040):711. PubMed ID: 71516
    [No Abstract]   [Full Text] [Related]  

  • 18. Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.
    Mohs RC; Shiovitz TM; Tariot PN; Porsteinsson AP; Baker KD; Feldman PD
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):752-9. PubMed ID: 19700948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems and prospects in the treatment of dementia.
    Dagon EM; Liebman A
    Wis Med J; 1982 Aug; 81(8):32-4. PubMed ID: 6753350
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose-related physostigmine-induced ventricular arrhythmia: case report.
    Dysken MW; Janowsky DS
    J Clin Psychiatry; 1985 Oct; 46(10):446-7. PubMed ID: 4044537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.